Low data variability

Our core ECG laboratory provides a centralised system for all our studies. High precision ECG acquisition in our clinic provides meaningful ECG analysis with a smaller sample size, making us the ideal choice for the integration of cardiac safety in FIH and MAD studies.

We are a leading publisher in cardiology and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.

Learn more about our ECG Lab

Exceptional ECG generation

We undertake and analyse several cardiological assessments using state-of-the-art equipment to understand and explain abnormal ECG data obtained during a clinical study of a new chemical entity.

Learn more about our Cardio Analysis Services

Experts in cardiac safety

Richmond Pharmacology’s Core ECG Laboratory team are based within St George’s Hospital Medical School, London and are made up of highly experienced cardiologists headed by Professor John Camm, a key opinion leader in TQT Trials.

Learn more about our expert cardiologists

Our new unit at St George's Hospital is open for business

8
January 2004

View Articles

Doors open on our new unit in Tooting

8
December 2003

View Articles

We're Expanding!

12
November 2003

View Articles

An incredible 17,000 volunteers recruited in just 17 months!

20
October 2003

Richmond Pharmacology has an exceptional volunteer database of over 17,000 volunteers and continues to outshine the competition, recruiting on average 1,000 new volunteers each month.

View Articles

e-CRFs mean speedier reviews

25
August 2003

We have established a new web-based system for online data entry of our CRFs (Case Report Forms).

View Articles

Early Warning - Nurse Call System

14
August 2003

installation of a specialised nurse call system

View Articles

Latest news

Patient safety is not an afterthought. Explore our new infographic!

September 17, 2025
Patient safety is not an afterthought; it is the foundation of every clinical trial.
Read more

Events

JSCPT 2025

5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event